Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has assisted KMC Properties in its merger with Logistea
Mandate

Vinge has assisted KMC Properties in its merger with Logistea

June 24, 2024

On June 14, 2024, KMC Properties ASA, listed on Oslo Børs, announced that the company is merging with Logistea AB (publ), listed on Nasdaq Stockholm.

The merger will be executed by Logistea acquiring all shares in KMC Properties HoldCo AS ("KMC HoldCo"), a wholly-owned subsidiary of KMC Properties, and thereby acquire all of the operations in the KMC Properties group, with payment in newly issued shares in Logistea. The transaction values KMC HoldCo at SEK 3.259 million.

Vinge's team mainly consisted of Jesper Schönbeck, Niclas Winnberg, Ulrich Ziche, Joel Wahlberg, Karolina Cohrs, Frida Ställborn, Adrian Filipovic, Agnes Pigg and Hanna Kövamees.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026